Understand the source comparison
Is IGF-1 LR3 Legal to Purchase for Research: Jurisdictional Comparison
United States Legal when purchased from FDA-registered 503B facilities for documented research purposes Must be FDA-registered 503B facility; submit to regular inspections; maintain cGMP compliance Research protocol on file; biosafety documentation; chain-of-c
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- United States
- Legal when purchased from FDA-registered 503B facilities for documented research purposes
- Must be FDA-registered 503B facility; submit to regular inspections; maintain cGMP compliance
- Research protocol on file; biosafety documentation; chain-of-custody records; no human use outside clinical trials
- Clear legal framework exists. Compliance depends on documentation quality and supplier verification
- European Union
- Legal under scientific research exemptions when purchased from licensed suppliers
- Must hold relevant national pharmaceutical manufacturing license; comply with EU GMP standards
- Research protocol approved by institutional ethics committee; compliance with Directive 2001/83/EC research exemptions
- Similar to U.S. framework but with additional member-state variations in licensing requirements
- United Kingdom
- Legal for research when supplied by MHRA-licensed entities or under research exemption provisions
- MHRA licensing or equivalent regulatory approval; compliance with UK GMP standards post-Brexit
- Protocol documentation; ethics approval for certain research types; compliance with Medicines Act 1968 research provisions
- Post-Brexit regulatory alignment with EU standards maintained for research peptides; supplier verification essential
- Australia
- Legal for research via TGA-approved suppliers under Special Access Scheme or research provisions
- TGA approval or relevant state/territory authorization; compliance with Australian GMP standards
- Institutional ethics approval; detailed research protocol; compliance with Therapeutic Goods Act 1989 research exemptions
- More restrictive framework than U.S.; institutional approval process often required before purchase
- Canada
- Legal for research when purchased from Health Canada-licensed suppliers
- Health Canada establishment license for manufacturing; compliance with Canadian GMP standards
- Research protocol documentation; institutional ethics review where applicable; compliance with Food and Drugs Act research provisions
- Robust regulatory framework; cross-border purchases from U.S. 503B facilities may face import complications